Blood viscosity predicts mortality in severe COVID-19: study
US data point to potential role of haemodynamic measures in predicting in-hospital death
Elevated whole blood viscosity in patients hospitalised with COVID-19 is associated with a more than 50% increased risk of death, results from the first large-scale study of its kind show.
According to US researchers, estimated high-shear blood viscosity — calculated via routine lab tests — could be used as a risk assessment tool to offer preventive therapy in this setting.
